DAVENPORT & Co LLC Buys 120,987 Shares of HealthEquity, Inc. (NASDAQ:HQY)

DAVENPORT & Co LLC lifted its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 31.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 507,135 shares of the company's stock after acquiring an additional 120,987 shares during the quarter. DAVENPORT & Co LLC owned approximately 0.59% of HealthEquity worth $33,636,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. O Shaughnessy Asset Management LLC lifted its position in shares of HealthEquity by 3.3% in the 2nd quarter. O Shaughnessy Asset Management LLC now owns 5,060 shares of the company's stock valued at $319,000 after acquiring an additional 160 shares in the last quarter. Fifth Third Bancorp increased its stake in HealthEquity by 36.5% in the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company's stock valued at $44,000 after buying an additional 161 shares during the period. Metropolitan Life Insurance Co NY increased its stake in HealthEquity by 3.6% in the 4th quarter. Metropolitan Life Insurance Co NY now owns 5,190 shares of the company's stock valued at $320,000 after buying an additional 179 shares during the period. Sheets Smith Wealth Management increased its stake in HealthEquity by 2.5% in the 3rd quarter. Sheets Smith Wealth Management now owns 7,921 shares of the company's stock valued at $579,000 after buying an additional 191 shares during the period. Finally, Thrivent Financial for Lutherans increased its stake in HealthEquity by 0.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 59,666 shares of the company's stock valued at $4,007,000 after buying an additional 196 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded down $2.88 during trading hours on Wednesday, hitting $79.90. 890,122 shares of the stock were exchanged, compared to its average volume of 615,311. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76. The company's 50 day moving average is $80.43 and its 200 day moving average is $73.67. The firm has a market capitalization of $6.86 billion, a P/E ratio of 124.84, a P/E/G ratio of 1.37 and a beta of 0.53. HealthEquity, Inc. has a one year low of $48.86 and a one year high of $84.49.

Insider Buying and Selling

In related news, CEO Jon Kessler sold 33,765 shares of the company's stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares of the company's stock, valued at approximately $10,106,739.35. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares of the company's stock, valued at approximately $10,106,739.35. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Delano Ladd sold 2,499 shares of the stock in a transaction on Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares of the company's stock, valued at $3,999,680. The disclosure for this sale can be found here. In the last three months, insiders sold 73,908 shares of company stock valued at $5,863,915. Company insiders own 2.70% of the company's stock.

Wall Street Analyst Weigh In

HQY has been the topic of several research reports. Bank of America upped their price objective on shares of HealthEquity from $93.00 to $97.00 and gave the company a "buy" rating in a research note on Wednesday, March 20th. KeyCorp upped their price objective on shares of HealthEquity from $85.00 to $95.00 and gave the company an "overweight" rating in a research note on Friday, March 22nd. JPMorgan Chase & Co. upped their price objective on shares of HealthEquity from $86.00 to $108.00 and gave the company an "overweight" rating in a research note on Tuesday. BTIG Research increased their price target on shares of HealthEquity from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, March 20th. Finally, Royal Bank of Canada increased their price target on shares of HealthEquity from $90.00 to $92.00 and gave the stock an "outperform" rating in a research note on Wednesday, March 20th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to MarketBeat.com, HealthEquity has a consensus rating of "Moderate Buy" and an average target price of $95.73.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.